Meyerson_1982_Pharmacol.Biochem.Behav_17_159

Reference

Title : Human brain receptor alterations in suicide victims - Meyerson_1982_Pharmacol.Biochem.Behav_17_159
Author(s) : Meyerson LR , Wennogle LP , Abel MS , Coupet J , Lippa AS , Rauh CE , Beer B
Ref : Pharmacol Biochem Behav , 17 :159 , 1982
Abstract :

A comparison was made of human postmortem muscarinic-cholinergic, beta-adrenergic and serotonergic (presynaptic) recognition sites in cortical tissues derived from suicide and homicide (control) victims. An elevation of 47% and 35% in the suicide group compared to controls was observed in receptor ligand binding for 3H-quinuclidinyl benzilate (QNB, muscarinic antagonist) and 3H-imipramine (IMI, a presynaptic serotonin marker), respectively. In contrast, no appreciable differences in 3H-dihydroalprenolol (DHA, beta-adrenergic antagonist) binding were observed between the two groups. Additionally, tissues from both groups of subjects were analyzed for tricyclic antidepressive agent (TAD) content. High performance liquid chromatographic (HPLC) tissue analysis revealed no detectable levels of tricyclic agents with an assay sensitivity of 50 picograms/mg tissue. The results presented herein demonstrate neurotransmitter-receptor alterations in suicide subjects compared to homicide (control) victims. The attendant roles of serotonergic and muscarinic-cholinergic processes in the psychobiology of suicide and depression are addressed.

PubMedSearch : Meyerson_1982_Pharmacol.Biochem.Behav_17_159
PubMedID: 6289359

Related information

Citations formats

Meyerson LR, Wennogle LP, Abel MS, Coupet J, Lippa AS, Rauh CE, Beer B (1982)
Human brain receptor alterations in suicide victims
Pharmacol Biochem Behav 17 :159

Meyerson LR, Wennogle LP, Abel MS, Coupet J, Lippa AS, Rauh CE, Beer B (1982)
Pharmacol Biochem Behav 17 :159